Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$TBPH

Theravance Biopharma, Inc.

XNASHealth CarePharmaceutical Preparations

$17.01
+0.35%+$0.060
RVOL peak today
Normal
Halted today
None today
Float
ultra-low
Next earnings
Unscheduled
$17.01+0.35%+$0.0600Prev $16.95LIVE Full chart Live alerts
No recent price bars, the chart lights up when TBPH starts printing.

Why is TBPH up today? It is at $17.01 (+0.35%). See the catalyst behind the move, real-time alerts the moment TBPH spikes, and full due diligence on TBPH — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $TBPH alerts the moment volume spikes

Be first to know when $TBPH makes an unusual move. Create a free account to track $TBPH, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$17.01
Change today
+0.35%
Previous close
$16.95
52-week range
$13.08 – $21.03
Valuation & dividend
Market cap
$883M
Ownership & volume
Shares outstanding
51.9M
SEC · as of 2026-07-31 · 23d
Insider ownership
7.8%
DEF 14A · 2026-04-28
Institutional own.
99.35%
Total held
100.0%
Short interest
4.2M
▼ -3% vs prior · as of 2026-07-31
Days to cover
7.5d
Avg daily volume
533K
Classification
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
XNAS
Relative volumevs this time of day
5m
0.3x
15m
0.4x
1h
0.8x
1D
--

Get free TBPH + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $TBPH moving today?

Here is the latest on TBPH from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TBPH today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

Why is $TBPH moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profile⚡ Ultra-low floatShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusHold3 analysts
Avg target $17.00(-0% downside)
Range $17 - $17
0 buy3 hold0 sell

Analyst data via Nasdaq. Not investment advice.

Insiders

Insiders buying6 buys, 6 sells last 3 months (11/26 over 12 months)
Show 12 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Samaha Eli
Beneficial Owner (10%)
Sold (automatic/other)-6K
0.01% of company
sold <0.1%9.17M$96K
at $17.17
Jul 7, 26
Samaha Eli
Beneficial Owner (10%)
Sold (automatic/other)-1Ksold <0.1%9.17M$24K
at $17.04
Jul 6, 26
Samaha Eli
Beneficial Owner (10%)
Sold (automatic/other)-38K
0.07% of company
sold 0.4%9.17M$643K
at $17.00
Jul 1, 26
Samaha Eli
Beneficial Owner (10%)
Sold (automatic/other)-25K
0.05% of company
sold 0.3%9.21M$429K
at $17.13
Jun 30, 26
Samaha Eli
Beneficial Owner (10%)
Sold (automatic/other)-274K
0.5% of company
sold 2.9%9.24M$4.7M
at $17.23
Jun 29, 26
Miller Aine
Officer
Acquired (grant/award)+19K
0.04% of company
added 11%196Kn/aJun 19, 26
Farnum Rhonda
Officer
Sold (automatic/other)-13K
0.03% of company
sold 5.4%232K$218K
at $16.38
Jun 15, 26
Pakianathan Deepika
Director
Acquired (grant/award)+6K
0.01% of company
added 10%64Kn/aJun 12, 26
O'Connor Donal
Director
Acquired (grant/award)+6K
0.01% of company
added 8.1%80Kn/aJun 12, 26
Mitchell Dean J
Director
Acquired (grant/award)+6K
0.01% of company
added 6.6%97Kn/aJun 12, 26
Gray Susannah
Director
Acquired (grant/award)+6K
0.01% of company
added 14%48Kn/aJun 12, 26
Smaldone Alsup Laurie
Director
Acquired (grant/award)+6K
0.01% of company
added 8.0%81Kn/aJun 12, 26

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

Dilution watch

Unavailable

We could not reach SEC EDGAR, so the dilution check did not run for $TBPH. This is not a clean result: there may be an offering, a registration or a shelf on file that we were unable to read. Check it yourself on SEC EDGAR before trading it.

$TBPH Sentiment

Neutral
Bearish51Bullish
📰 News: 2 bull · 2 bearToday: +0.4%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$TBPH Activity

News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

Related PHARMACEUTICAL stocks

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

TBPH stock FAQ

Why is $TBPH moving today?

Here is the latest on TBPH from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TBPH today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

What is the TBPH stock price today?

TBPH last traded at $17.01, up 0.35% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live TBPH alerts?

The TBPH Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TBPH 0 times in the last 30 days.

What exchange is TBPH on?

TBPH (Theravance Biopharma, Inc.) trades on XNAS, with a market cap of about $883M in the PHARMACEUTICAL PREPARATIONS sector.

Is TBPH good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TBPH for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.